WHO
For scientists, process development teams, manufacturing leaders, CMC specialists and supply chain professionals involved in oligonucleotide, peptide and next-generation Oligos & Peptides Manufacturing across Ireland, the UK and Europe.
WHAT
A dedicated gathering focused on oligonucleotide and peptide development, manufacturing, analytical characterisation, formulation, scale-up, fill-finish, supply chain and regulatory strategy.
WHY
As demand for oligonucleotide and peptide therapeutics continues to accelerate, manufacturers are scaling capacity, advancing technologies and strengthening supply chains across Europe. Connect with the innovators, CDMOs and technology providers driving the future of TIDES manufacturing and commercialisation.
John Bridgeman | CSO, Immunokey, UK
"Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal."
Terry Gray | Field Marketing Manager, Merck
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. The organisers were exceptionally receptive and helpful, ensuring a seamless experience throughout the planning, exhibition logistics, partnering sessions, and sponsor visibility. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."
